A Post-Marketing Observational Study to Evaluate the Effectiveness of Adalimumab in Patients With Moderately to Severely Active Rheumatoid Arthritis in China

Update Il y a 4 ans
Reference: NCT01464021

Woman and Man

  • | Country :
  • China
  • | organs :
  • -
  • | Specialty :
  • -

Extract

A post-marketing uncontrolled observational study to explore and describe the effectiveness of adalimumab, as prescribed according to the local product label, in patients with moderately to severely active rheumatoid arthritis (RA) in China.


Inclusion criteria

  • Arthritis ,Rheumatoid

Links